INVESTIGATION OF PROLONGED DRUG RELEASE FROM MATRIX FORMULATIONS OF CHITOSAN

被引:83
|
作者
NIGALAYE, AG [1 ]
ADUSUMILLI, P [1 ]
BOLTON, S [1 ]
机构
[1] FOREST LABS INC,INWOOD,NY
关键词
D O I
10.3109/03639049009114897
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A hydrocolloidal matrix system containing complexes of chitosan was investigated for preparation of sustained release tablets and examined in-vitro. Theophylline tablets using chitosan as a sustained release base were evaluated. It was found that when chitosan is used in a concentration of more than 50% of tablet weight, an insoluble non-erosion type matrix was formed. Tablets prepared with a chitosan concentration of less than 33% were fast releasing. Chitosan used in a concentration of about 10% acted as a disintegrant and the drug was dissolved within an hour. Citric acid slowed down the release rates of chitosan based theophylline tablets. Theophylline tablets using carbomer-934P as a sustained release base were evaluated. Carbomer-934P in lower concentrations forms an erosion type matrix. In order to produce a twenty-four (24) hour sustained release tablet, more than 10% concentration of carbomer-934P is needed. Combination with chitosan and carbomer-934P produced slower releasing tablets. A hydrocolloidal erosion type matrix was formulated using chitosan, carbomer-934Pand citric acid. Only 10% of chitosan was needed to prepare theophylline sustained release tablets in these mixtures. The dose dumping potential of chitosan tablets due to rapid disintegration in alkaline media was eliminated by preparing hydrated erosion type matrix systems. © 1990 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.
引用
收藏
页码:449 / 467
页数:19
相关论文
共 50 条
  • [1] New formulations based on salicyl-imine-chitosan hydrogels for prolonged drug release
    Iftime, Manuela-Maria
    Tartau, Liliana Mititelu
    Marin, Luminita
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2020, 160 : 398 - 408
  • [2] PROLONGED DRUG RELEASE FROM A CYLINDRICAL MATRIX DEVICE WITH A SMALL RELEASE HOLE
    Tojo, Kakuji
    CHEMICAL ENGINEERING COMMUNICATIONS, 1984, 30 (06) : 311 - 322
  • [3] THE DRUG RELEASE FROM LIPOSOMAL CARRIER WITHIN THE CHITOSAN MATRIX
    Chiang, Hongsen
    Huang, Yi-Cheng
    Yeh, Huei-Yu
    Yeh, Szu-Yi
    Huang, Yi-You
    BIOMEDICAL ENGINEERING-APPLICATIONS BASIS COMMUNICATIONS, 2009, 21 (02): : 107 - 114
  • [4] FACTORS INFLUENCING RELEASE OF DRUG FROM PROLONGED-ACTION MATRIX
    LAZARUS, J
    PAGLIERY, M
    LACHMAN, L
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1964, 53 (07) : 798 - &
  • [5] POLYACRYLATE TERPOLYMER FOR PROLONGED DRUG-RELEASE TYPE FORMULATIONS
    RAK, J
    VITKOVA, M
    CHALABALA, M
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1993, 39 (03) : 117 - 119
  • [6] Trends in controlled drug release formulations using chitin and chitosan
    Gupta, KC
    Kumar, MNVR
    JOURNAL OF SCIENTIFIC & INDUSTRIAL RESEARCH, 2000, 59 (03): : 201 - 213
  • [7] Drug physical state and drug-polymer interaction on drug release from chitosan matrix films
    Puttipipatkhachorn, S
    Nunthanid, J
    Yamamoto, K
    Peck, GE
    JOURNAL OF CONTROLLED RELEASE, 2001, 75 (1-2) : 143 - 153
  • [8] Overview on chitin and chitosan applications with an emphasis on controlled drug release formulations
    Gupta, Kailash C.
    Ravi Kumar, Majeti N. V.
    Journal of Macromolecular Science - Reviews in Macromolecular Chemistry and Physics, 2000, 40
  • [9] An overview on chitin and chitosan applications with an emphasis on controlled drug release formulations
    Gupta, KC
    Kumar, MNVR
    JOURNAL OF MACROMOLECULAR SCIENCE-REVIEWS IN MACROMOLECULAR CHEMISTRY AND PHYSICS, 2000, C40 (04): : 273 - 308
  • [10] Impact of salt form and molecular weight of chitosan on swelling and drug release from chitosan matrix tablets
    Huanbutta, Kampanart
    Cheewatanakornkool, Kamonrak
    Terada, Katsuhide
    Nunthanid, Jurairat
    Sriamornsak, Pornsak
    CARBOHYDRATE POLYMERS, 2013, 97 (01) : 26 - 33